370 related articles for article (PubMed ID: 33303535)
1. Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages.
Gillan JL; Davidson DJ; Gray RD
Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33303535
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches.
Ghigo A; Prono G; Riccardi E; De Rose V
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669352
[TBL] [Abstract][Full Text] [Related]
3. Targeting airway inflammation in cystic fibrosis.
McElvaney OJ; Wade P; Murphy M; Reeves EP; McElvaney NG
Expert Rev Respir Med; 2019 Nov; 13(11):1041-1055. PubMed ID: 31530195
[No Abstract] [Full Text] [Related]
4. Airway Inflammation and Host Responses in the Era of CFTR Modulators.
Keown K; Brown R; Doherty DF; Houston C; McKelvey MC; Creane S; Linden D; McAuley DF; Kidney JC; Weldon S; Downey DG; Taggart CC
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887484
[TBL] [Abstract][Full Text] [Related]
5. Inflammation in cystic fibrosis: An update.
Roesch EA; Nichols DP; Chmiel JF
Pediatr Pulmonol; 2018 Nov; 53(S3):S30-S50. PubMed ID: 29999593
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators.
Perrem L; Ratjen F
Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S46-S55. PubMed ID: 31715088
[TBL] [Abstract][Full Text] [Related]
7. CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis.
Saluzzo F; Riberi L; Messore B; Loré NI; Esposito I; Bignamini E; De Rose V
Cells; 2022 Apr; 11(7):. PubMed ID: 35406809
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR Modulators.
Wang S; Niroula S; Hoffman A; Khorrami M; Khorrami M; Yuan F; Gasser GN; Choi S; Liu B; Li J; Metersky ML; Vincent M; Crum CP; Boucher RC; Karmouty-Quintana H; Huang HJ; Sheshadri A; Dickey BF; Parekh KR; Engelhardt JF; McKeon FD; Xian W
Am J Respir Crit Care Med; 2023 Nov; 208(9):930-943. PubMed ID: 37695863
[No Abstract] [Full Text] [Related]
9. The impact of CFTR modulator therapies on CF airway microbiology.
Rogers GB; Taylor SL; Hoffman LR; Burr LD
J Cyst Fibros; 2020 May; 19(3):359-364. PubMed ID: 31416774
[TBL] [Abstract][Full Text] [Related]
10. [Evidence-based treatment of cystic fibrosis].
Ringshausen FC; Hellmuth T; Dittrich AM
Internist (Berl); 2020 Dec; 61(12):1212-1229. PubMed ID: 33201261
[TBL] [Abstract][Full Text] [Related]
11. Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies.
Carbone A; Vitullo P; Di Gioia S; Conese M
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895314
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function.
Zhang S; Shrestha CL; Kopp BT
Sci Rep; 2018 Nov; 8(1):17066. PubMed ID: 30459435
[TBL] [Abstract][Full Text] [Related]
13. Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications.
Mall MA; Mayer-Hamblett N; Rowe SM
Am J Respir Crit Care Med; 2020 May; 201(10):1193-1208. PubMed ID: 31860331
[TBL] [Abstract][Full Text] [Related]
14. Loss of CFTR function in macrophages alters the cell transcriptional program and delays lung resolution of inflammation.
Wellems D; Hu Y; Jennings S; Wang G
Front Immunol; 2023; 14():1242381. PubMed ID: 38035088
[TBL] [Abstract][Full Text] [Related]
15. An update on new and emerging therapies for cystic fibrosis.
Hudock KM; Clancy JP
Expert Opin Emerg Drugs; 2017 Dec; 22(4):331-346. PubMed ID: 29264936
[TBL] [Abstract][Full Text] [Related]
16. Treating the Underlying Cystic Fibrosis Transmembrane Conductance Regulator Defect in Patients with Cystic Fibrosis.
Cuyx S; De Boeck K
Semin Respir Crit Care Med; 2019 Dec; 40(6):762-774. PubMed ID: 31659727
[TBL] [Abstract][Full Text] [Related]
17. Rapid therapeutic advances in CFTR modulator science.
Clancy JP
Pediatr Pulmonol; 2018 Nov; 53(S3):S4-S11. PubMed ID: 30289627
[TBL] [Abstract][Full Text] [Related]
18. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
[TBL] [Abstract][Full Text] [Related]
19. The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis.
Harvey C; Weldon S; Elborn S; Downey DG; Taggart C
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408875
[TBL] [Abstract][Full Text] [Related]
20. CFTR: cystic fibrosis and beyond.
Mall MA; Hartl D
Eur Respir J; 2014 Oct; 44(4):1042-54. PubMed ID: 24925916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
